29 June 2020: Articles
Giant Inflammatory Polyps in Diverticular Disease Mimicking a Colonic Mass: A Potential Malignant Masquerader
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Clinical situation which can not be reproduced for ethical reasonsRoula Katerji1D*, Aaron R. Huber1A
Am J Case Rep 2020; 21:e923242
BACKGROUND: Inflammatory pseudopolyps (IPPs) are a common manifestation in inflammatory bowel disease (IBD) with more cases reported with ulcerative colitis than Crohn’s disease. IPPs can grow to form large polyps which are called giant inflammatory polyps (GIPs). These polyps may cause an obstruction and form a mass-like lesion and surgical resection may be warranted.
CASE REPORT: A 65-year-old male without a previous history of IBD presented with abdominal discomfort, poor appetite, constipation, weight loss, and hematochezia. Due to the high suspicion of malignancy, a computed tomography (CT) scan was performed and showed a fixed lesion in the mid sigmoid colon highly concerning for a primary colon carcinoma, with scattered diverticula, and associated with elevated carcinoembryonic antigen (CEA). Colonoscopy was done but the scope could not be passed due to obstruction. Sigmoidectomy was performed which showed a huge noninvasive lesion, which looked like pseudopolypoid serpiginous mass as giant inflammatory polyp, with scattered diverticula. On microscopic examination, pathology showed a villous polyp with numerous inflammatory cells, without any dysplasia or carcinoma.
CONCLUSIONS: GIPs are rarely reported without a history of IBD. Diagnosis of GIPs can be very challenging, and surgery is sometimes indicated for definitive diagnosis.
Keywords: Colonic Neoplasms, colonic polyps, Diverticulum, Colon, Aged, Carcinoembryonic Antigen, Colon, Sigmoid, Constipation, Diagnosis, Differential, Diverticulum, Gastrointestinal Hemorrhage, Tomography, X-Ray Computed
Diverticular disease is common in western countries and occurs in patients over the age of 40 years with an incidence of 33–66%, and up to 25% of these patients will develop acute diverticulitis; other complications of diverticular disease are hemorrhage, perforation, and fistulas. Inflammatory pseudo-polyps (IPPs) or giant inflammatory polyps (GIPs) have not been previously discussed as one of the complications or sequelae of long-standing diverticular disease.
IPPs and GIPs have been well documented in the literature as being associated with patients with IBD, specifically ulcerative colitis disease . Ghandi et al. did a retrospective analysis of over 70 patients with IPPs, excluding patients with IBD, and found that 26% of IPPs were found in patients with diverticular disease , which confirms that IPPs can be seen in diver-ticular disease as well as IBD.
Inflammatory polyps and pseudopolyps are formed due to enlarged mucosal tags, by repeated peristalsis and fecal stream and by the continuous regenerative and healing processes of the ulcerated epithelium, and with time the ulcerated epithelium exposed to mucosal traction and fecal stream predispose to the formation of inflammatory polyps . The presence of IPPs in patients with IBD can be a sign of previous episodes of inflammation and the presence of IPPs is a marker of the degree of colitis [1,4]. Although the mechanism of IPPs in patients with diverticulosis has not been widely studied, it was reported previously that IPPs developed in a patient after diverticulitis . One theory is that the development process is similar to the process seen in patients with IBD, where during the flare episode of diverticulitis mucosal edema, chronic inflammation develops in the mucosa and forms the polyp.
Sometimes these polyps grow and become large, and when they are larger than 1.5 cm, they are called GIPs, which have the appearance of a “mass of worms” or a “fungating mass”. These polyps can also form masses that can be mistaken clinically for colorectal adenocarcinoma. There are rare reports of dysplasia developing in GIPs in IBD patients , so careful evaluation of the epithelium surface is mandatory to evaluate for dysplasia and also to exclude other neoplastic processes, checking the surface for maturation which is usually seen in reactive and regenerating epithelium but not in dysplasia is crucial.
A 19-cm segment of the sigmoid colon (sigmoid resection) was removed; it had a tan focally congested and smooth serosa. On the serosa there was a 5.4×2.8 cm strictured area in the center of the specimen. At the strictured area, the mucosa displayed a 5.9×5.8 cm circumferential area consisting of a red-brown pseudopolypoid, serpiginous, and worm-like mass. On sectioning, the pseudopolypoid lesions appeared confined to the mucosa with no gross invasion into the underlying wall. The wall was gray-white and fibrotic with scattered 0.2 cm possible abscess cavities containing yellow-white, purulent material with possible exudate. Within the pseudopolypoid area, there were multiple diverticula present. The remaining colonic mucosa was tan-pink, glistening, and focally congested with scattered diverticula (Figure 2).
Microscopic examination of the polypoid area revealed villous-like polyps with irregular projections of the mucosa lined by hyperplastic mucosa containing numerous inflammatory cells, and marked acute inflammation with cystically dilated glands, as well as neutrophilic cryptitis and crypt abscesses (Figure 3). Mucosal erosion and smooth muscle thickening were also present (Figure 4). Mucosal and sub-mucosal lymphoid aggregates were identified (Figure 5A, 5B). The rest of the mucosa was lined by un-remarkable colonic mucosa. No dysplasia or adenocarcinoma was identified. Forty-one lymph nodes were negative for malignancy.
IPPs and GIPs are common in patients with IBD, most commonly located in the transverse colon followed by the descending colon . In our patient, there was no previous history of IBD, diverticulitis, or diverticulosis. His diverticula were seen at the time of imaging which suggested that the patient could have had previous undocumented inflammation before the time of presentation. GIPs have rarely been reported in the literature to present without IBD, mimicking colonic carcinoma [8,9].
Usually, patients with GIPs present with hematochezia, weight loss, obstruction, and abdominal pain with discomfort . It has been proposed that GIPs presentation are correlated with the duration and severity of IBD . GIP is a common pitfall for clinicians and radiologists because it is similar to neoplastic lesions and is frequently mistaken as colon cancer, as in our case which was highly suspicious for malignancy which prompted large surgical excision and thorough evaluation of lymph node metastasis.
The differential diagnosis of IPP and GIP includes mucosal pro-lapse-induced polyp. Mucosal prolapsed-induced polyps, especially in the left colon, might be confused with IPPs and colon cancer. These polyps have areas of hyperplastic glands, epithelial denudation; polymorphic inflammatory infiltrate in lamina propria, with dense fibrosis and vascular congestion. Mucosal pro-lapse polyps show fibromuscular hypertrophy that extends into the lamina propria, which are not present in IPPs . Other entities in the differential diagnosis may include villous adenoma, but there is no dysplastic epithelium, and possibly lymphoma depending on the degree of amount of inflammatory infiltrate present.
Our patient had a slight increase in CEA which might be another pitfall for considering malignancy, but CEA can be elevated in non-malignant conditions like smoking, IBD, pancreatitis, and cirrhosis .
The prognosis for GIPs is usually good, with rare recurrences reported, and the presence of inflammation at the resection margin might predict recurrence or persistence of the disease .
As for treatment, IPPs might regress after healing of the underlying process. Depending on the severity and the size of the polyp, the treatment can be divided into medical treatment and endoscopic or surgical intervention. Mesalazine and azathioprine have been used successfully in IBD patients with GIPs . In general, surgery is not mandatory for IPPs and GIPs if endoscopic biopsies do not show invasive tumor [16,17]. Endoscopic polypectomy is another method for removal of IPPS . When endoscopic therapies like polypectomy fail to manage complications like obstruction, intussusception, or uncontrolled bleeding, then surgical procedures like hemicolectomy or sigmoid segmental resection might be required and inevitable.
In summary, we present a new case of GIP in a patient with an incidental finding of diverticulosis presenting as colonic obstruction and a mass-like lesion invoking a strong clinical suspicion for a primary colonic neoplasm. Pathologists, surgeons, and gastroenterologists should be aware of this entity and the potential that it may masquerade as a colonic mass-like lesion with obstruction. The major clinical question is a surgical resection necessary is such a case? The answer depends on the clinical situation and if complications such as obstruction are present or if there is a high index of suspicion for a colonic neoplasm. In those instances, surgery to relieve the patient’s symptoms and provide a definitive pathologic diagnosis is warranted. However, medical management might be an option in other instances.
GIPs are rarely seen in patients without a previous history of diverticulitis, or IBD. GIPs might present as a neoplasm mimicking a colonic malignancy. In this case, the patient’s history, elevated tumor marker levels, and imaging studies made the clinical team consider malignancy. The diagnosis of GIP is very challenging and sometimes cannot be accurately diagnosed without surgery.
FiguresFigure 1.. Computed tomography scan revealed a fixed lesion in the mid sigmoid colon at approximately 36 cm from the anal verge concerning for a primary colon carcinoma. Figure 2.. Gross photo of the sigmoid colon with giant inflammatory polyp. Figure 3.. Inflammatory polyp with crypt abscess (hematoxylin and eosin-stained section, original magnification 100×). Figure 4.. Mucosal erosion and smooth muscle thickening (hematoxylin and eosin-stained sections, original magnification 20×). Figure 5.. (A, B) Mucosal and sub-mucosal lymphoid aggregates are present (hematoxylin and eosin-stained sections, original magnification 40×, 20×, respectively).
1.. Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK, Pseudopolyps in inflammatory bowel diseases: Have we learned enough?: World J Gastroenterol, 2017; 23; 1541-51
2.. Gandhi AV, Malik SM, Palazzo JP, Colorectal inflammatory pseudopolyps: A retrospective analysis of 70 patients: Open J Pathol, 2014; 4(3); 7
3.. Lumb G, Pathology of ulcerative colitis: Gastroenterology, 1961; 40; 290-98
4.. Nagashima M, Sugishita Y, Moriyama A, Tumor-like growth of giant inflammatory polyposis in a patient with ulcerative colitis: Case Rep Gastroenterol, 2013; 7; 352-57
5.. Seo HI, Two hyperemic polypoid lesions in the colon: Intes Res, 2016; 14; 379-80
6.. Dukes CE, The surgical pathology of ulcerative colitis: Ann R Coll Surg Engl, 1954; 14; 389-400
7.. Maggs JRL, Browning LC, Warren BF, Travis SPL, Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature: J Crohns Colitis, 2008; 2; 170-80
8.. Wolf EM, Strasser C, Geboes K, Localized giant inflammatory polyp of the colon in a patient without inflammatory bowel disease: Virchows Archiv, 2011; 459; 245-46
9.. Tan KH, Meijer S, Donner R, Giant localized pseudopolyp of the colon without colonic inflammatory disease – case report: Neth J Surg, 1987; 39; 95-97
10.. Naymagon S, Mikulasovich M, Gui X, Crohn’s-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: A potential diagnostic pitfall: J Crohns Colitis, 2014; 8; 635-40
11.. Abou Rached A, Saba J, El Masri L, Obstructive giant inflammatory polyposis: Is it related to the severity or the duration of the inflammatory bowel disease? Two case reports: Case Rep Gastrointest Med, 2018; 2018; 3251549
12.. Chetty R, Bhathal PS, Slavin JL, Prolapse-induced inflammatory polyps of the colorectum and anal transitional zone: Histopathology, 1993; 23; 63-67
13.. Perkins GL, Slater ED, Sanders GK, Prichard JG, Serum tumor markers: Am Fam Physician, 2003; 68; 1075-82
14.. Sheikholeslami MR, Schaefer RF, Mukunyadzi P, Diffuse giant inflammatory polyposis: A challenging clinicopathologic diagnosis: Arch Pathol Lab Med, 2004; 128; 1286-88
15.. Choi YS, Suh JP, Lee IT, Regression of giant pseudopolyps in inflammatory bowel disease: J Crohns Colitis, 2012; 6; 240-43
16.. Katz S, Rosenberg RF, Katzka I, Giant pseudopolyps in Crohn’s colitis. A non-operative approach: Am J Gastroenterol, 1981; 76; 267-71
17.. Lim YJ, Choi JH, Yang CH, What is the clinical relevance of filiform polyposis?: Gut Liver, 2012; 6; 524-26
18.. Rutter M, Saunders B, Emmanuel A, Price A, Endoscopic snare polypectomy for bleeding postinflammatory polyps: Endoscopy, 2003; 35; 788-90
04 Oct 2023 : Clinical ResearchA Retrospective Study of 205 Patients with Complex Kidney Stones to Compare Outcomes from Super-Mini Percut...
Med Sci Monit In Press; DOI: 10.12659/MSM.941012
03 Oct 2023 : Clinical ResearchPrevalence and Risk Factors for Modic Changes in Symptomatic Cervical Ossification of the Posterior Longitu...
Med Sci Monit In Press; DOI: 10.12659/MSM.941674
03 Oct 2023 : Clinical ResearchTime-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insight...
Med Sci Monit In Press; DOI: 10.12659/MSM.941553
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292